BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10640692)

  • 1. AP-2beta represses D(1A) dopamine receptor gene transcription in neuro2a cells.
    Takeuchi S; Imafuku I; Waragai M; Roth C; Kanazawa I; Buettner R; Mouradian MM; Okazawa H
    Brain Res Mol Brain Res; 1999 Dec; 74(1-2):208-16. PubMed ID: 10640692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the human p11 promoter sequence.
    Huang X; Pawliczak R; Yao XL; Madara P; Alsaaty S; Shelhamer JH; Cowan MJ
    Gene; 2003 May; 310():133-42. PubMed ID: 12801640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53.
    Marreiros A; Czolij R; Yardley G; Crossley M; Jackson P
    Gene; 2003 Jan; 302(1-2):155-64. PubMed ID: 12527206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular regulation of the human IL-3 gene: inducible T cell-restricted expression requires intact AP-1 and Elf-1 nuclear protein binding sites.
    Gottschalk LR; Giannola DM; Emerson SG
    J Exp Med; 1993 Nov; 178(5):1681-92. PubMed ID: 8228815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of CD2 gene expression is mediated by an AP-2 related factor.
    Outram SV; Grimwade D; Crompton T
    Biochem Biophys Res Commun; 2001 Feb; 281(2):409-15. PubMed ID: 11181063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
    Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
    Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An enhancer element 6 kb upstream of the mouse HNF4alpha1 promoter is activated by glucocorticoids and liver-enriched transcription factors.
    Bailly A; Torres-Padilla ME; Tinel AP; Weiss MC
    Nucleic Acids Res; 2001 Sep; 29(17):3495-505. PubMed ID: 11522818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
    Anisowicz A; Sotiropoulou G; Sager R
    Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZIC2 and Sp3 repress Sp1-induced activation of the human D1A dopamine receptor gene.
    Yang Y; Hwang CK; Junn E; Lee G; Mouradian MM
    J Biol Chem; 2000 Dec; 275(49):38863-9. PubMed ID: 10984499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of AP-2alpha and AP-2beta in the developing chick retina: repression of R-FABP promoter activity by AP-2.
    Bisgrove DA; Godbout R
    Dev Dyn; 1999 Mar; 214(3):195-206. PubMed ID: 10090146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZNF143 mediates basal and tissue-specific expression of human transaldolase.
    Grossman CE; Qian Y; Banki K; Perl A
    J Biol Chem; 2004 Mar; 279(13):12190-205. PubMed ID: 14702349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proximal promoter of the surfactant protein D gene: regulatory roles of AP-1, forkhead box, and GT box binding proteins.
    He Y; Crouch EC; Rust K; Spaite E; Brody SL
    J Biol Chem; 2000 Oct; 275(40):31051-60. PubMed ID: 10915785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rat growth hormone and human cellular retinol binding protein 1 genes share homologous NF1-like binding sites that exert either positive or negative influences on gene expression in vitro.
    Leclerc S; Eskild W; Guérin SL
    DNA Cell Biol; 1997 Aug; 16(8):951-67. PubMed ID: 9303437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rat growth hormone proximal silencer contains a novel DNA-binding site for multiple nuclear proteins that represses basal promoter activity.
    Roy RJ; Vallières L; Leclerc S; Guérin SL
    Eur J Biochem; 1994 Oct; 225(1):419-32. PubMed ID: 7925464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noradrenergic-specific transcription of the dopamine beta-hydroxylase gene requires synergy of multiple cis-acting elements including at least two Phox2a-binding sites.
    Kim HS; Seo H; Yang C; Brunet JF; Kim KS
    J Neurosci; 1998 Oct; 18(20):8247-60. PubMed ID: 9763470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of D1A dopamine receptor gene transcription by estrogen.
    Lee SH; Mouradian MM
    Mol Cell Endocrinol; 1999 Oct; 156(1-2):151-7. PubMed ID: 10612433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exon-I is involved in positive as well as negative regulation of human angiotensinogen gene expression.
    Cui Y; Narayanan CS; Zhou J; Kumar A
    Gene; 1998 Dec; 224(1-2):97-107. PubMed ID: 9931457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the tyrosine hydroxylase and dopamine beta-hydroxylase genes by the transcription factor AP-2.
    Kim HS; Hong SJ; LeDoux MS; Kim KS
    J Neurochem; 2001 Jan; 76(1):280-94. PubMed ID: 11146001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of AP-1-, AP-2-, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response.
    Descheemaeker KA; Wyns S; Nelles L; Auwerx J; Ny T; Collen D
    J Biol Chem; 1992 Jul; 267(21):15086-91. PubMed ID: 1634545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.